Module 3 2019

New Product Formats and Processes

• Requires a rethinking of the CMC setup and capabilities

• Demand a high knowledge of the drug product

• CMC must more tightly align with research

• Needs closer dialogues with regulatory agencies in order to confidently know what scientific evidence will be demanded

• Demands much more capacity for analytical testing

CMC Project Management

The Organisation for Professionals in Regulatory Affairs